A glycogen synthase kinase 3-β promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression
Abstract
The molecular mechanisms driving the biological clock in the suprachiasmatic nucleus of the hypothalamus may play a role in mood disorders. A single nucleotide polymorphism (SNP) (-50T/C) falling into the effective promoter region (nt -171 to +29) of the gene coding for glycogen synthase kinase 3-beta (GSK3-beta) has been linked with different age at onset of bipolar illness. GSK3-beta codes for an enzyme which is a target for the action of lithium and valproic acid, and the inhibition of which causes antidepressant-like behaviors in a preclinical model. We studied the effect of this polymorphism on the acute response to total sleep deprivation of 60 depressed bipolar type I inpatients. Homozygotes for the mutant allele of GSK3-beta promoter (-50T/C) SNP showed a later onset of bipolar illness, and better acute effects of TSD treatment on perceived mood (as rated on VAS). Overall, these observations suggest a protective role for this genotype in respect to bipolar illness. Results warrant interest for the variants of genes pertaining to the molecular clock as possible endophenotypes of bipolar disorder, and for GSK3-beta as a target of a new class of antidepressant drugs, but caution ought to be taken in interpreting these preliminary results and future replication studies must be awaited because of the low frequency of the GSK3-beta*C/C genotype in the studied populations.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Other studies failed to show a general association between the GSK3β SNPs and bipolar disorder.
“other studies failed to show a general association between these SNPs and BPD”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Benedetti et al., 2004
The GSK3β −50 T to C SNP is linked to a later age of onset of bipolar disorder.
“one of these SNPs (−50 T to C) is linked to a later age of onset of BPD and a greater response to total sleep deprivation (TSD) and long-term lithium treatment (Benedetti et al., 2004; Benedetti et al., 2005).”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Benedetti et al., 2004
The GSK3β −50 T to C SNP is linked to a greater response to total sleep deprivation in bipolar patients.
“one of these SNPs (−50 T to C) is linked to a later age of onset of BPD and a greater response to total sleep deprivation (TSD) and long-term lithium treatment (Benedetti et al., 2004; Benedetti et al., 2005).”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Benedetti et al., 2004
The GSK3β −50 T to C SNP is linked to a greater response to long-term lithium treatment in bipolar patients.
“one of these SNPs (−50 T to C) is linked to a later age of onset of BPD and a greater response to total sleep deprivation (TSD) and long-term lithium treatment (Benedetti et al., 2004; Benedetti et al., 2005).”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Benedetti et al., 2004
Cites
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,305 · see citing works
The glamour and gloom of glycogen synthase kinase-3
Jope, R. S., & Johnson, G. V. W. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.004 · Cited by 1,522 · see citing works
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,429 · see citing works
A Role for the Segment Polarity Gene shaggy/GSK-3 in the Drosophila Circadian Clock
Martinek, S., Inonog, S., Manoukian, A. S., & Young, M. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00383-x · Cited by 513 · see citing works
Chen, A. C. H., Shirayama, Y., Shin, K.-H., Neve, R. L., & Duman, R. S. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01114-8 · Cited by 314 · see citing works
Newton, S. S., Thome, J., Wallace, T. L., Shirayama, Y., Schlesinger, L., Sakai, N., Chen, J., Neve, R., Nestler, E. J., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10883.2002 · Cited by 313 · see citing works
Kaidanovich‐Beilin, O., Milman, A., Weizman, A., Pick, C. G., & Eldar-Finkelman, H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.008 · Cited by 276 · see citing works
Endophenotypes in bipolar disorder
Lenox, R. H., Gould, T. D., & Manji, H. K. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10360 · Cited by 264 · see citing works
BDNF‐mediated signal transduction is modulated by GSK3β and mood stabilizing agents
Mai, L., Jope, R. S., & Li, X. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00939.x · Cited by 195 · see citing works
Benedetti, F., Serretti, A., Colombo, C., Campori, E., Barbini, B., di Bella, D., & Smeraldi, E. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1450 · Cited by 167 · see citing works
Benedetti, F., Bernasconi, A., Lorenzi, C., Pontiggia, A., Serretti, A., Colombo, C., & Smeraldi, E. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.10.021 · Cited by 162 · see citing works
Rhythms and the pharmacology of lithium
Klemfuss, H. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90037-z · Cited by 134 · see citing works
Expression analysis of glycogen synthase kinase‐3 in human tissues
Lau, K., Miller, C. C. J., Anderton, B. H., & Shaw, P. C. (1999) · Journal of Peptide Research · doi:10.1034/j.1399-3011.1999.00083.x · Cited by 113 · see citing works
Retraction of an Interpretation
Zhang, L., Lopez, P., Tian, H., Yu, W., & Ho, D. D. (2004) · Science · doi:10.1126/science.303.5657.467b · Cited by 112 · see citing works
Gasparini, P., Estivill, X., Volpini, V., Totaro, A., Castellvı́-Bel, S., Govea, N., Milà, M., Monica, M. D., Ventruto, N. V., Benedetto, M. D., et al. (1997) · PubMed · Cited by 108 · see citing works
Totaro, A., P., G., Estivill, X., Volpini, V., Castellvı́-Bel, S., Govea, N., Milà, M., Monica, M. D., Ventruto, V., Benedetto, M. D., et al. (1997) · European Journal of Human Genetics · doi:10.1159/000484738 · Cited by 105 · see citing works
Benedetti, F., Colombo, C., Serretti, A., Lorenzi, C., Pontiggia, A., Barbini, B., & Smeraldi, E. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01894-2 · Cited by 90 · see citing works
Wirz‐Justice, A., Terman, M., Oren, D. A., Goodwin, F. K., Kripke, D. F., Whybrow, P. C., Wisner, K. L., Wu, J. C., Lam, R. W. M., Berger, T., et al. (2004) · Science · doi:10.1126/science.303.5657.467c · Cited by 78 · see citing works
Badenhop, R. F., Moses, M. J., Scimone, A., Mitchell, P. B., Ewen-White, K. R., Rosso, A., Donald, J. A., Adams, L. J., & Schofield, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001025 · Cited by 73 · see citing works
Molecular Cloning and Characterization of the Human Glycogen Synthase Kinase-3β Promoter
Lau, K., Miller, C. C. J., Anderton, B. H., & Shaw, P. (1999) · Genomics · doi:10.1006/geno.1999.5875 · Cited by 67 · see citing works
Glycogen synthase kinase-3β, β-catenin, and tau in postmortem bipolar brain
Lesort, M. J., Greendorfer, A., Stockmeier, C. A., Johnson, G. V. W., & Jope, R. S. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050235 · Cited by 62 · see citing works
Badenhop, R. F., Moses, M. J., Scimone, A., Mitchell, P. B., Ewen-White, K. R., Rosso, A., Donald, J. A., Adams, L. J., & Schofield, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001114 · Cited by 61 · see citing works
Russ, C., Lovestone, S., & Powell, J. F. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000852 · Cited by 60 · see citing works
Effects of lithium ions on glycogen synthase and phosphorylase in rat hepatocytes.
Bosch, F., Gómèz‐Foix, A. M., Ariño, J., & Guinovart, J. J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75978-x · Cited by 50 · see citing works
Hansen, L., Arden, K. C., Rasmussen, S., Viars, C. S., Vestergaard, H., Hansen, T. F., Møller, A. M., Woodgett, J. R., & Pedersen, O. B. (1997) · Diabetologia · doi:10.1007/s001250050771 · Cited by 39 · see citing works
Antimanic drugs stabilize hamster circadian rhythms
Klemfuss, H., & Kripke, D. F. (1995) · Psychiatry Research · doi:10.1016/0165-1781(95)02687-r · Cited by 35 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763 · see citing works
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Beurel, E., Grieco, S. F., & Jope, R. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.016 · Cited by 1,768 · see citing works
Circadian genes, rhythms and the biology of mood disorders
McClung, C. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.02.003 · Cited by 666 · see citing works
Nuclear Receptor Rev-erbα Is a Critical Lithium-Sensitive Component of the Circadian Clock
Yin, L., Wang, J., Klein, P. S., & Lazar, M. A. (2006) · Science · doi:10.1126/science.1121613 · Cited by 556 · see citing works
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Beaulieu, J., Gainetdinov, R. R., & Caron, M. G. (2008) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 523 · see citing works
Toward constructing an endophenotype strategy for bipolar disorders
Hasler, G., Drevets, W. C., Gould, T. D., Gottesman, I. I., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.006 · Cited by 423 · see citing works
Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs
Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 377 · see citing works
Machado‐Vieira, R., Manji, H. K., & Zarate, C. A. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00714.x · Cited by 370 · see citing works
Biological rhythm disturbances in mood disorders
Wirz‐Justice, A. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000195660.37267.cf · Cited by 356 · see citing works
Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?
Li, X., & Jope, R. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.105 · Cited by 294 · see citing works
Inhibition of GSK3 by lithium, from single molecules to signaling networks
Freland, L., & Beaulieu, J. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00014 · Cited by 269 · see citing works
Circadian rhythms and sleep in bipolar disorder
Murray, G., & Harvey, A. G. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00843.x · Cited by 250 · see citing works
Beaulieu, J. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110011 · Cited by 237 · see citing works
The ups and downs of Wnt signaling in prevalent neurological disorders
Ferrari, G. V. D., & Moon, R. T. (2006) · Oncogene · doi:10.1038/sj.onc.1210064 · Cited by 221 · see citing works
Sleep Disturbance in Bipolar Disorder: Therapeutic Implications
Plante, D. T., & Winkelman, J. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08010077 · Cited by 268 · see citing works
Circadian rhythm in bipolar disorder: A review of the literature
Takaesu, Y. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12688 · Cited by 217 · see citing works
Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm
Shi, J., Wittke‐Thompson, J. K., Badner, J. A., Hattori, E., Potash, J. B., Willour, V. L., McMahon, F. J., Gershon, E. S., & Liu, C. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30714 · Cited by 211 · see citing works
Le‐Niculescu, H., Patel, S. D., Bhat, M., Kuczenski, R., Faraone, S. V., Tsuang, M. T., McMahon, F. J., Schork, N. J., Nurnberger, J. I., & Niculescu, A. B. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30887 · Cited by 201 · see citing works
Benedetti, F., Serretti, A., Pontiggia, A., Bernasconi, A., Lorenzi, C., Colombo, C., & Smeraldi, E. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.022 · Cited by 184 · see citing works
Self-citationCircadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder
Bunney, B. G., Li, J. Z., Walsh, D. M. A., Stein, R., Vawter, M. P., Cartagena, P. M., Barchas, J. D., Schatzberg, A. F., Myers, R., Watson, S. J., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.138 · Cited by 185 · see citing works
Glycogen Synthase Kinase-3 in the Etiology and Treatment of Mood Disorders
Jope, R. S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00016 · Cited by 174 · see citing works
Mármol, F. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.08.012 · Cited by 174 · see citing works
Lithium and GSK3-β Promoter Gene Variants Influence White Matter Microstructure in Bipolar Disorder
Benedetti, F., Bollettini, I., Barberi, I., Radaelli, D., Poletti, S., Locatelli, C., Pirovano, A., Lorenzi, C., Falini, A., Colombo, C., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.172 · Cited by 164 · see citing works
Mansour, H. A., Talkowski, M. E., Wood, J., Chowdari, K. V., McClain, L., Prasad, K., Montrose, D., Fagiolini, A., Friedman, E. S., Allen, M. H., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00756.x · Cited by 161 · see citing works
Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors
Beaulieu, J. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00038 · Cited by 159 · see citing works
Peterson, M. J., & Benca, R. M. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.09.003 · Cited by 164 · see citing works
Circadian genes and bipolar disorder
Mansour, H., Monk, T. H., & Nimgaonkar, V. L. (2005) · Annals of Medicine · doi:10.1080/07853890510007377 · Cited by 142 · see citing works
Alloy, L. B., Nusslock, R., & Boland, E. M. (2015) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032814-112902 · Cited by 135 · see citing works
The bipolarity of light and dark: A review on Bipolar Disorder and circadian cycles
Abreu, T., & Bragança, M. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.07.017 · Cited by 131 · see citing works
Kaladchibachi, S., Doble, B. W., Anthopoulos, N., Woodgett, J. R., & Manoukian, A. S. (2007) · Journal of Circadian Rhythms · doi:10.1186/1740-3391-5-3 · Cited by 128 · see citing works
Circadian abnormalities, molecular clock genes and chronobiological treatments in depression
Bunney, J., & Potkin, S. G. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn019 · Cited by 124 · see citing works
Disruption of the Circadian Timing Systems
Mendlewicz, J. (2009) · CNS Drugs · doi:10.2165/11318630-000000000-00000 · Cited by 122 · see citing works
Early identification and high‐risk strategies for bipolar disorder
Correll, C. U., Penzner, J. B., Lencz, T., Auther, A. M., Smith, C. W., Malhotra, A. K., Kane, J. M., & Cornblatt, B. A. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00487.x · Cited by 121 · see citing works
Molecular actions and clinical pharmacogenetics of lithium therapy
Can, A., Schulze, T. G., & Gould, T. D. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.02.004 · Cited by 121 · see citing works
Lewis, K. S., Gordon‐Smith, K., Forty, L., Florio, A. D., Craddock, N. J., Jones, L. A., & Jones, I. R. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.117.202259 · Cited by 121 · see citing works
Lee, K. W., Woon, P. S., Teo, Y. Y., & Sim, K. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.09.001 · Cited by 117 · see citing works
Tau Phosphorylation by GSK3 in Different Conditions
Ávila, J., León‐Espinosa, G., García, E., García‐Escudero, V., Hernández, F., & DeFelipe, J. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/578373 · Cited by 119 · see citing works
Circadian depression: A mood disorder phenotype
Carpenter, J. S., Crouse, J. J., Scott, E. M., Naismith, S. L., Wilson, C., Scott, J., Merikangas, K. R., & Hickie, I. B. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.045 · Cited by 114 · see citing works
Sleep Deprivation in Mood Disorders
Benedetti, F., & Colombo, C. (2011) · Neuropsychobiology · doi:10.1159/000328947 · Cited by 116 · see citing works
Scaini, G., Valvassori, S. S., Díaz, A. P., Lima, C. N. D. C., Benevenuto, D., Fries, G. R., & Quevedo, J. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0732 · Cited by 114 · see citing works
Le-Niculescu, H., McFarland, M. J., Ogden, C. A., Balaraman, Y., Patel, S. D., Tan, J., Rodd, Z. A., Paulus, M. P., Geyer, M. A., Edenberg, H. J., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30707 · Cited by 108 · see citing works
The role of the phosphatidylinositide 3-kinase–protein kinase B pathway in schizophrenia
Kalkman, H. O. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.014 · Cited by 106 · see citing works
Sleep- and circadian rhythm–associated pathways as therapeutic targets in bipolar disorder
Bellivier, F., Geoffroy, P.-A., Etain, B., & Scott, J. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1018822 · Cited by 104 · see citing works
Adli, M., Hollinde, D. L., Stamm, T. J., Wiethoff, K., Tsahuridu, M., Kirchheiner, J., Heinz, A., & Bauer, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.023 · Cited by 100 · see citing works
Clock gene variants in mood and anxiety disorders
Partonen, T. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0810-2 · Cited by 99 · see citing works
Translational research in bipolar disorder: emerging insights from genetically based models
Chen, G., Henter, I. D., & Manji, H. K. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.3 · Cited by 95 · see citing works
Applications of blood-based protein biomarker strategies in the study of psychiatric disorders
Chan, M. K., Gottschalk, M. G., Haenisch, F., Tomasik, J., Ruland, T., Rahmoune, H., Guest, P. C., & Bahn, S. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.08.002 · Cited by 94 · see citing works
Qiu, H., Zhong, R., Liu, H., Zhang, F., Li, S., & Le, W. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150774 · Cited by 94 · see citing works
Ritter, P. S., Marx, C., Lewtschenko, N., Pfeiffer, S., Leopold, K., Bauer, M., & Pfennig, A. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0883-y · Cited by 92 · see citing works
Biological rhythms and chronotherapeutics in depression
Geoffroy, P. A., & Palagini, L. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110158 · Cited by 127 · see citing works
Pilar-Cuéllar, F., Vidal, R., Díaz, Á., Castro, E., dos Anjos, S., Pascual-Brazo, J., Linge, R., Vargas, V., Blanco, H., Martínez-Villayandre, B., et al. (2013) · Journal of Neural Transplantation and Plasticity · doi:10.1155/2013/537265 · Cited by 93 · see citing works
de Bartolomeis, A., Buonaguro, E. F., & Iasevoli, F. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2921-8 · Cited by 89 · see citing works
Circadian biomarkers, circadian genes and bipolar disorders
Milhiet, V., Étain, B., Boudebesse, C., & Bellivier, F. (2011) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2011.07.002 · Cited by 87 · see citing works
Sleep Deprivation Therapy for Depression
Dallaspezia, S., & Benedetti, F. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_363 · Cited by 83 · see citing works
Pharmacogenetics in the treatment of depression: pharmacodynamic studies
Serretti, A., Artioli, P., & Quartesan, R. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200502000-00001 · Cited by 78 · see citing works
Chronobiological therapy for mood disorders
Dallaspezia, S., & Benedetti, F. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.61 · Cited by 77 · see citing works
Melatonin, circadian rhythms, and the clock genes in bipolar disorder
Dallaspezia, S., & Benedetti, F. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0074-1 · Cited by 77 · see citing works
Szczepankiewicz, A., RYBAKOWSKI, J. K., Suwalska, A., Skibińska, M., Leszczyńska-Rodziewicz, A., Dmitrzak‐Węglarz, M., Czerski, P. M., & Hauser, J. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970600554711 · Cited by 73 · see citing works
Li, S., Liu, L.-J., Xu, L., Gao, L., Wang, X., Zhang, J., & Lü, L. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.07.009 · Cited by 71 · see citing works
Severino, G., Manchia, M., Contu, P., Squassina, A., Lampus, S. F., Ardau, R., Chillotti, C., & Zompo, M. D. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00667.x · Cited by 70 · see citing works
Chronobiological Therapy for Mood Disorders
Dallaspezia, S., Suzuki, M., & Benedetti, F. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0633-6 · Cited by 68 · see citing works
Kishi, T., Kitajima, T., Ikeda, M., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Okochi, T., Ozaki, N., & Iwata, N. (2008) · Neuroscience Research · doi:10.1016/j.neures.2008.08.008 · Cited by 67 · see citing works
Tsai, S.-J., Liou, Y.-J., Hong, C.-J., Yu, Y. W.-Y., & Chen, T.-J. (2008) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500486 · Cited by 66 · see citing works
The Role of Mammalian Circadian Proteins in Normal Physiology and Genotoxic Stress Responses
Kondratov, R. V., Gorbacheva, V., & Antoch, M. P. (2007) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)78005-x · Cited by 64 · see citing works
Psychotropic drugs affect Ser9-phosphorylated GSK-3β protein levels in rodent frontal cortex
Kozlovsky, N., Amar, S., Belmaker, R. H., & Agam, G. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006097 · Cited by 65 · see citing works
Osorio, R. S., Ducca, E. L., Wohlleber, M. E., Tanzi, E. B., Gumb, T., Twumasi, A., Tweardy, S., Lewis, C., Fischer, E., Koushyk, V., et al. (2016) · SLEEP · doi:10.5665/sleep.5846 · Cited by 64 · see citing works
Rapid-acting antidepressants and the circadian clock
Sato, S., Bunney, B. G., Mendoza-Viveros, L., Bunney, W. E., Borrelli, E., Sassone‐Corsi, P., & Orozco-Solís, R. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01241-w · Cited by 65 · see citing works
Lin, K., Huang, M., & Liu, H. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.08.025 · Cited by 62 · see citing works
Benedetti, F., & Smeraldi, E. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788957447 · Cited by 60 · see citing works
Benedetti, F., Poletti, S., Radaelli, D., Bernasconi, A., Cavallaro, R., Falini, A., Lorenzi, C., Pirovano, A., Dallaspezia, S., Locatelli, C., et al. (2010) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2010.00566.x · Cited by 59 · see citing works
Genetic Factors Affecting Seasonality, Mood, and the Circadian Clock
Garbazza, C., & Benedetti, F. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00481 · Cited by 55 · see citing works
Zhang, K., Yang, C.-X., Xu, Y., Sun, N., Yang, H., Liu, J.-L., Xu, Q., & Shen, Y. (2010) · Journal of neural transmission · doi:10.1007/s00702-009-0360-4 · Cited by 58 · see citing works
The Wnt Pathway in Mood Disorders
Sani, G., Napoletano, F., Forte, A. M., Kotzalidis, G. D., Panaccione, I., Porfiri, G. M., Simonetti, A., Caloro, M., Girardi, N., Telesforo, C. L., et al. (2012) · Current Neuropharmacology · doi:10.2174/157015912803217279 · Cited by 55 · see citing works
Lee, K. Y., Ahn, Y. M., Joo, E.-J., Jeong, S.-H., Chang, J. S., Kim, S.-C., & Kim, Y. S. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.059 · Cited by 54 · see citing works
Chronobiology of mood disorders
Malhi, G. S., & Kuiper, S. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12173 · Cited by 53 · see citing works
Lithium's role in neural plasticity and its implications for mood disorders
Gray, J. D., & McEwen, B. S. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12139 · Cited by 54 · see citing works
Melatonin and Its Agonist Ramelteon in Alzheimer′s Disease: Possible Therapeutic Value
Srinivasan, V., Kaur, C., Pandi-Perumal, S. R., Brown, G. M., & Cardinali, D. P. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/741974 · Cited by 53 · see citing works
SOUSA, R. T. D., Zanetti, M. V., Talib, L. L., Serpa, M. H., Chaim, T. M., Carvalho, A. F., Brunoni, A. R., Busatto, G. F., Gattaz, W. F., & Machado‐Vieira, R. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.01.016 · Cited by 52 · see citing works
Chronobiology of Bipolar Disorder: Therapeutic Implication
Dallaspezia, S., & Benedetti, F. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0606-9 · Cited by 53 · see citing works
Saus, E., Soria, V., Escaramís, G., Crespo, J. M., Valero, J., Gutiérrez‐Zotes, A., Martorell, L., Vilella, E., Menchón, J. M., Estivill, X., et al. (2010) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2010.00617.x · Cited by 51 · see citing works
Pogorelov, V. M., Nomura, J., Kim, J., Kannan, G., Ayhan, Y., Yang, C., Taniguchi, Y., Abazyan, B. N., Valentine, H., Krasnova, I. N., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.003 · Cited by 51 · see citing works
Review: Clock genes at the heart of depression
Kennaway, D. J. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810372980 · Cited by 49 · see citing works
Benedetti, F., Dallaspezia, S., Lorenzi, C., Pirovano, A., Radaelli, D., Locatelli, C., Poletti, S., Colombo, C., & Smeraldi, E. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.039 · Cited by 49 · see citing works
Chen, X., Feng, L., Cai, B., Chen, X., & Chen, G. (2017) · The Journal of Comparative Neurology · doi:10.1002/cne.24311 · Cited by 48 · see citing works
Antidepressant chronotherapeutics for bipolar depression
Benedetti, F. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.4/fbenedetti · Cited by 49 · see citing works
Tomasetti, C., Dell’Aversano, C., Iasevoli, F., Marmo, F., & de Bartolomeis, A. (2011) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.10.025 · Cited by 49 · see citing works
Geoffroy, P. A., Boudebesse, C., Henrion, A., Jamain, S., Henry, C., Leboyer, M., Bellivier, F., & Étain, B. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12103 · Cited by 46 · see citing works
The role of glycogen synthase kinase 3 beta in multiple sclerosis.
Noori, T., Dehpour, A., Sureda, A., Fakhri, S., Sobarzo-Sánchez, E., Farzaei, M., Akkol, E. K., Khodarahmi, Z., Hosseini, S. Z., Alavi, S. D., et al. (2020) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2020.110874 · Cited by 41 · see citing works
Biological rhythms and mood disorders
Salvatore, P., Indic, P., Murray, G., & Baldessarini, R. J. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.4/psalvatore · Cited by 45 · see citing works
Furlotti, G., Alisi, M. A., Cazzolla, N., Dragone, P., Durando, L., Magarò, G., Mancini, F., Mangano, G., Ombrato, R., Vitiello, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01208 · Cited by 43 · see citing works
Serretti, A., Benedetti, F., Mandelli, L., Calati, R., Caneva, B., Lorenzi, C., Fontana, V., Colombo, C., & Smeraldi, E. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2007.06.017 · Cited by 43 · see citing works
Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilising medications
Gould, T. D. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.3.377 · Cited by 40 · see citing works
The genetics of early-onset bipolar disorder: A systematic review
Kennedy, K. P., Cullen, K. R., DeYoung, C. G., & Klimes‐Dougan, B. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.05.017 · Cited by 39 · see citing works
Can the response to mood stabilizers be predicted in bipolar disorder
Geoffroy, P. A. (2014) · Frontiers in Bioscience-Elite · doi:10.2741/e696 · Cited by 39 · see citing works
Signaling Pathways Involved in Antidepressant-Induced Cell Proliferation and Synaptic Plasticity
Pilar-Cuéllar, F., Vidal, R., Díaz, Á., Castro, E., Dos-Anjos, S., Vargas, V. I., Romero, B., & Valdizán, E. M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660736 · Cited by 36 · see citing works
Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder
Benedetti, F., Poletti, S., Radaelli, D., Locatelli, C., Pirovano, A., Lorenzi, C., Vai, B., Bollettini, I., Falini, A., Smeraldi, E., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3770-4 · Cited by 37 · see citing works
Genetic association of BDNF val66met and GSK‐3β‐50T/C polymorphisms with tardive dyskinesia
Park, S. W., Lee, J. G., Kong, B. G., Lee, S. J., Lee, C. H., Kim, J. I., & Kim, Y. H. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01976.x · Cited by 35 · see citing works
Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer’s Disease
Sequeira, R. C., & Godad, A. P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03839-1 · Cited by 30 · see citing works
Association analysis of the glycogen synthase kinase-3β gene in bipolar disorder
Nishiguchi, N., Breen, G. D., Russ, C., Clair, D. S., & Collier, D. A. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.042 · Cited by 29 · see citing works
Sleep deprivation as a method of chronotherapy in the treatment of depression
Dopierała, E., & RYBAKOWSKI, J. K. (2015) · Psychiatria Polska · doi:10.12740/pp/30455 · Cited by 28 · see citing works
- Authors
- Benedetti, F., Serretti, A., Colombo, C., Lorenzi, C., Tubazio, V., & Smeraldi, E.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- IRCCS Ospedale San Raffaele (IT)
- Corresponding author
- Benedetti, Francesco
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 368
- Issue
- 2
- Pages
- 123-126
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2080758948
- Cited by
- 195
- References
- 26
- Citations by year
- 2026: 3 · 2025: 2 · 2023: 2 · 2022: 4 · 2021: 27 · 2020: 6 · 2019: 3 · 2018: 6 · 2017: 6 · 2016: 8 · 2015: 13 · 2014: 11 · 2013: 9 · 2012: 15
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience Letters (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- glycogen synthase kinase-3β, single nucleotide polymorphisms, total sleep deprivation, bipolar depression, bipolar I disorder, age of onset, genetic susceptibility, circadian clock, suprachiasmatic nucleus, mood disorders, antidepressant targets, endophenotypes
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Adult, Alleles, Analysis of Variance, Bipolar Disorder, DNA Mutational Analysis, Female, Genotype, Humans, Male, Middle Aged, Mutation, Promoter Regions, Genetic, Sleep Deprivation, Age of Onset, Genetic Predisposition to Disease, Reverse Transcriptase Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Glycogen Synthase Kinase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review